Addressing the Burden of Psoriatic Arthritis: Moving Beyond the Joint
Philip J. Mease, MD, and Alexis R. Ogdie-Beatty, MD, review the pathogenesis and a wide spectrum of clinical features, manifestations, and comorbidities of psoriatic arthritis; talk about classification criteria for PsA and different patient-reported and provider-assessed outcome measures; and discuss treatment recommendations and strategies, as well as various types of current and emerging ther...
|
|
Addressing the Burden of Rheumatoid Arthritis and Psoriatic Arthritis: Early Recognition and Initial Treatment
In this slide deck Daniel J. Wallace, MD, has reviewed the pathogenesis of rheumatic arthritis (RA) and psoriatic arthritis (PsA) as well as the core principles of treatment of RA and PsA. He addresses the clinical features, manifestations, and comorbidities of RA and PsA and their differential diagnoses. Finally, covers the guidelines-based treatment recommendations, while stressing the importa...
|
|
Diagnosing Rare Diseases Brings New Treatment to Patients - Education for Advanced Care Practitioners
Barbara K. Burton, MD, presents an approach to recognizing lysosomal storage disorders (LSDs). Difficulty recognizing LSDs is a major barrier to their treatment, and Dr. Burton illustrates how clinicians can spot missed- or mis-diagnosed LSDs using 5 case studies. The disorders that Dr. Burton focuses on are LSDs that have treatments available or in late-stage clinical trials. After focusing on ...
|
|
|
Navigating Advancements in Diagnosis & Treatment of Axial Spondyloarthritis
More than 80% of the population has significant back pain at some point in their life, with 30% of adults in the United States stating they have chronic low back pain at any given time; 5% of whom have inflammatory back pain. Axial spondyloarthritis (axSpA) affects almost 1.5% of patients with inflammatory back pain; however, the majority of individuals suffering with back pain are not being tre...
|
Navigating the Recent Rheumatoid Arthritis Guidelines to Achieve Disease Remission and Reduce Patient
Roy M. Fleischmann, MD, discusses the latest evidence for the management of patients with moderate-to-severe rheumatoid arthritis who do not achieve treatment goals with initial disease-modifying anti-rheumatic drug therapy. A key treatment principle emphasized by Dr. Fleischmann is using a treat-to-target approach guided by validated tools for assessing disease activity and patient-reported out...
|
|
|
Research Developments in Atopic Dermatitis
Welcome to this activity focusing on new research related to atopic dermatitis presented as posters at the 2020 virtual annual meetings of the American Academy of Dermatology and the American Academy of Allergy, Asthma, and Immunology. The posters focus on new data related to the use of advanced therapies for atopic dermatitis. Beyond discussing the methods and results of each poster, the facult...
|
Research Developments in Rheumatoid Arthritis
The past decade has provided numerous advances in the treatment of rheumatoid arthritis. As will be discussed, recent evidence of 2 medications from different classes provide reassurance as to their long-term safety and efficacy. Of key importance is that these treatment advances provide a real opportunity to achieve disease remission using a treat-to-target approach. The benefits of achieving l...
|
|
Shifting Focus: Individualizing Preventive Therapy for Hereditary Angioedema
William Lumry, MD, FACAAI, discusses the genetic component of HAE and differences among the types of HAE. This activity also includes several eye-opening video clips from patients with HAE who describe how it affects their daily lives.
Content Areas:
• Burden of disease
• Clinical presentation, features
• Causes and types
• Diagnosis and screening
• Approaches to treatment
•...
|
|